ATLAS / Macro Radar / Reporting / FBRX

Forte Biosciences, Inc. (FBRX) reporting calendar

Forte Biosciences, Inc. files periodic reports with the SEC as FBRX on Nasdaq. Atlas tracks 37 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
21 Jul 2026 – 7 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
11 May 2026
Reports on record
37

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open FBRX market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202611 May 202641 days0001193125-26-215862
10-K31 Dec 202531 Mar 202690 days0001193125-26-134498
10-Q30 Sep 202514 Nov 202545 days0001193125-25-281808
10-Q30 Jun 202514 Aug 202545 days0000950170-25-108889
10-Q31 Mar 202515 May 202545 days0000950170-25-072569
10-K31 Dec 202428 Mar 202587 days0000950170-25-046749
10-Q30 Sep 202414 Nov 202445 days0000950170-24-127031
10-Q30 Jun 202414 Aug 202445 days0000950170-24-096988
10-Q31 Mar 202413 May 202443 days0000950170-24-058669
10-K31 Dec 202318 Mar 202478 days0000950170-24-032843
10-Q30 Sep 202313 Nov 202344 days0000950170-23-062907
10-Q30 Jun 202314 Aug 202345 days0000950170-23-042518
10-Q31 Mar 202315 May 202345 days0000950170-23-022184
10-K31 Dec 202231 Mar 202390 days0000950170-23-011355
10-Q30 Sep 202214 Nov 202245 days0000950170-22-024977
10-Q30 Jun 202215 Aug 202246 days0000950170-22-017378
10-Q31 Mar 202216 May 202246 days0001564590-22-020257
10-K31 Dec 202131 Mar 202290 days0001564590-22-012987
10-Q30 Sep 20218 Nov 202139 days0001564590-21-055083
10-Q30 Jun 202116 Aug 202147 days0001564590-21-044463
10-Q31 Mar 202110 May 202140 days0001564590-21-026044
10-K31 Dec 202016 Mar 202175 days0001564590-21-013249
10-Q30 Sep 20209 Nov 202040 days0001564590-20-052509
10-Q30 Jun 202010 Aug 202041 days0001564590-20-038950
10-Q31 Mar 202023 Apr 202023 days0001564590-20-018200
10-K31 Dec 201927 Feb 202058 days0001564590-20-007402
10-Q30 Sep 201912 Nov 201943 days0001564590-19-042987
10-Q30 Jun 20198 Aug 201939 days0001564590-19-030897
10-Q31 Mar 20197 May 201937 days0001564590-19-016543
10-K31 Dec 201827 Feb 201958 days0001564590-19-004933
10-Q30 Sep 20188 Nov 201839 days0001564590-18-028639
10-Q30 Jun 20189 Aug 201840 days0001564590-18-021106
10-Q31 Mar 201811 May 201841 days0001564590-18-013236
10-K31 Dec 20179 Mar 201868 days0001564590-18-005132
10-Q30 Sep 20178 Nov 201739 days0001564590-17-022849
10-Q30 Jun 20179 Aug 201740 days0001564590-17-017036
10-Q31 Mar 201723 May 201753 days0001564590-17-011571

Source: SEC EDGAR company submissions for CIK 0001419041. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.